Literature DB >> 15321871

Nausea and vomiting associated with cancer chemotherapy: drug management in theory and in practice.

E S Antonarakis1, R D W Hain.   

Abstract

The function of cytotoxics is to damage cells, and it makes teleological sense for the body to expel them as soon after ingestion as possible. Ideally, from the body's point of view, they should simply be avoided, and it is not surprising that the experience of chemotherapy induced nausea and vomiting (CINV) is powerfully aversive. Nausea and vomiting were once among the most intractable and unpleasant experiences of a child undergoing treatment for cancer.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15321871      PMCID： PMC1763197          DOI： 10.1136/adc.2003.037341

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


  38 in total

1.  In vitro effects of combination chemotherapy on osteoblasts: implications for osteopenia in childhood malignancy.

Authors:  J H Davies; B A J Evans; M E M Jenney; J W Gregory
Journal:  Bone       Date:  2002-08       Impact factor: 4.398

Review 2.  Chemotherapy-induced nausea and vomiting.

Authors:  Catherine M Bender; Roxanne W McDaniel; Kathleen Murphy-Ende; Mary Pickett; Cynthia N Rittenberg; Miriam P Rogers; Susan M Schneider; Rowena N Schwartz
Journal:  Clin J Oncol Nurs       Date:  2002 Mar-Apr       Impact factor: 1.027

3.  Comparison of tropisetron and granisetron in the control of nausea and vomiting in children receiving combined cancer chemotherapy.

Authors:  S Aksoylar; S A Akman; F Ozgenç; S Kansoy
Journal:  Pediatr Hematol Oncol       Date:  2001-09       Impact factor: 1.969

4.  Safety, tolerability, antiemetic efficacy, and pharmacokinetics of oral dolasetron mesylate in pediatric cancer patients receiving moderately to highly emetogenic chemotherapy.

Authors:  M J Coppes; R Yanofsky; S Pritchard; J M Leclerc; D R Howard; M Perrotta; S Keays; A Pyesmany; E Dempsey; C B Pratt
Journal:  J Pediatr Hematol Oncol       Date:  1999 Jul-Aug       Impact factor: 1.289

5.  Delayed nausea and vomiting in children receiving antineoplastics.

Authors:  L L Dupuis; R Lau; M L Greenberg
Journal:  Med Pediatr Oncol       Date:  2001-08

6.  A comparison of oral ondansetron syrup or intravenous ondansetron loading dose regimens given in combination with dexamethasone for the prevention of nausea and emesis in pediatric and adolescent patients receiving moderately/highly emetogenic chemotherapy.

Authors:  L White; S A Daly; C J McKenna; N Zhestkova; C Leal; F Breatnach; V Smelhaus; I J Hung; J Kowalczyk; J Ninane; T Mitchell; C Haigh
Journal:  Pediatr Hematol Oncol       Date:  2000-09       Impact factor: 1.969

7.  Ondansetron and tropisetron in the control of nausea and vomiting in children receiving combined cancer chemotherapy.

Authors:  E Stiakaki; S Savvas; E Lydaki; I Bolonaki; E Kouvidi; H Dimitriou; A Kambourakis; M Kalmanti
Journal:  Pediatr Hematol Oncol       Date:  1999 Mar-Apr       Impact factor: 1.969

8.  Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting.

Authors:  Sant P Chawla; Steven M Grunberg; Richard J Gralla; Paul J Hesketh; Cindy Rittenberg; Mary E Elmer; Carrie Schmidt; Arlene Taylor; Alexandra D Carides; Judith K Evans; Kevin J Horgan
Journal:  Cancer       Date:  2003-05-01       Impact factor: 6.860

Review 9.  Delayed emesis following anticancer chemotherapy.

Authors:  M G Kris; F Roila; P H De Mulder; M Marty
Journal:  Support Care Cancer       Date:  1998-05       Impact factor: 3.603

10.  The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin--the Aprepitant Protocol 052 Study Group.

Authors:  Paul J Hesketh; Steven M Grunberg; Richard J Gralla; David G Warr; Fausto Roila; Ronald de Wit; Sant P Chawla; Alexandra D Carides; Juliana Ianus; Mary E Elmer; Judith K Evans; Klaus Beck; Scott Reines; Kevin J Horgan
Journal:  J Clin Oncol       Date:  2003-10-14       Impact factor: 44.544
View more
  3 in total

Review 1.  Feeding Intolerance in Children with Severe Impairment of the Central Nervous System: Strategies for Treatment and Prevention.

Authors:  Julie Hauer
Journal:  Children (Basel)       Date:  2017-12-22

Review 2.  Antiemetic medication for prevention and treatment of chemotherapy-induced nausea and vomiting in childhood.

Authors:  Robert S Phillips; Amanda J Friend; Faith Gibson; Elizabeth Houghton; Shireen Gopaul; Jean V Craig; Barry Pizer
Journal:  Cochrane Database Syst Rev       Date:  2016-02-02

3.  Recent advances in pharmacotherapy of chemotherapy-induced nausea and vomiting.

Authors:  Prasan R Bhandari
Journal:  J Adv Pharm Technol Res       Date:  2012-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.